KLTO - MCAP CO - Klotho Neurosciences Inc

This chart of Klotho Neurosciences Inc (KLTO) stock quotes showcases a company developing Klotho protein-based biologics to combat ALS and dementia. The current metric stands at . The business relies on stable demand for biotechnology, establishing it as a defensive asset regardless of macroeconomic conditions. Klotho Neurosciences Inc also focuses on Parkinson's disease therapy, aiming to restore cognitive functions in the elderly.

Klotho Neurosciences Inc (KLTO) operates in the high-risk neurobiological research sector without current operating revenue. Business value here depends not on profit, but on the market valuation of the potential for future therapeutic discoveries. Market capitalization represents the product of the share price and the total number of issued securities. This indicator reflects the aggregate investor demand for the company's scientific achievements. By analyzing the market capitalization dynamics of Klotho Neurosciences Inc (KLTO), one can identify periods of speculative overheating or asset undervaluation.